Chijioke Nze

Peer-Reviewed Articles

1. Nze C, Flowers CR. Barriers to accessing cellular therapy for patients receiving care in community practices. Hematology Am Soc Hematol Educ Program 2023(1):382-385, 2023. PMID: 38066850.
2. Nze C, Msaouel P, Derbala MH, Stephen B, Abonofal A, Meric-Bernstam F, Tannir NM, Naing A. A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma. Cancers 15(15):3806, 2023.
3. Li A, De Las Pozas G, Andersen CR, Nze CC, Toale KM, Milner EM, Fillmore NR, Chiao EY, Rojas Hernandez C, Kroll MH, Merriman KW, Flowers CR. External validation of a novel electronic risk score for cancer-associated thrombosis in a comprehensive cancer center. Am J Hematol 98(7):1052-1057, 2023. e-Pub 2023. PMID: 37067102.
4. Nwanaji-Enwerem JC, Nze C, Cardenas A. Long-term Aspirin Use and Epigenetic Mitotic Clocks for Cancer Risk Prediction: Findings in Healthy Colon Mucosa and Recommendations for Future Epigenetic Aging Studies. Epigenetics Commun 1(1), 2021. e-Pub 2021. PMID: 35493198.
5. Nze C, Fortin B, Freedman R, Mandell E, Puligandla M, Neuberg D, Achebe M. Sudden death in sickle cell disease: current experience. Br J Haematol 188(4):e43-e45, 2020. e-Pub 2019. PMID: 31804704.
6. Eberly LA, Richterman A, Beckett AG, Wispelwey B, Marsh RH, Cleveland Manchanda EC, Chang CY, Glynn RJ, Brooks KC, Boxer R, Kakoza R, Goldsmith J, Loscalzo J, Morse M, Lewis EF, Abel S, Adams A, Anaya J, Andrews EH, Atkinson B, Avutu V, Bachorik A, Badri O, Bailey M, Baird K, Bakshi S, Balaban D, Barshop K, Baumrin E, Bayomy O, Beamesderfer J, Becker N, Berg DD, Berman AN, Blum SM, Boardman AP, Boden K, Bonacci RA, Brown S, Campbell K, Case S, Cetrone E, Charrow A, Chiang D, Clark D, Cohen AJ, Cooper A, Cordova T, Cuneo CN, de Feria AA, Deffenbacher K, DeFilippis EM, DeGregorio G, Deutsch AJ, Diephuis B, Divakaran S, Dorschner P, Downing N, Drescher C, D'Silva KM, Dunbar P, Duong D, Earp S, Eckhardt C, Elman SA, England R, Everett K, Fedotova N, Feingold-Link T, Ferreira M, Fisher H, Foo P, Foote M, Franco I, Gilliland T, Greb J, Greco K, Grewal S, Grin B, Growdon ME, Guercio B, Hahn CK, Hasselfeld B, Haydu EJ, Hermes Z, Hildick-Smith G, Holcomb Z, Holroyd K, Horton L, Huang G, Jablonski S, Jacobs D, Jain N, Japa S, Joseph R, Kalashnikova M, Kalwani N, Kang D, Karan A, Katz JT, Kellner D, Kidia K, Kim JH, Knowles SM, Kolbe L, Kore I, Koullias Y, Kuye I, Lang J, Lawlor M, Lechner MG, Lee K, Lee S, Lee Z, Limaye N, Lin-Beckford S, Lipsyc M, Little J, Loewenthal J, Logaraj R, Lopez DM, Loriaux D, Lu Y, Ma K, Marukian N, Matias W, Mayers JR, McConnell I, McLaughlin M, Meade C, Meador C, Mehta A, Messenger E, Michaelidis C, Mirsky J, Mitten E, Mueller A, Mullur J, Munir A, Murphy E, Nagami E, Natarajan A, Nsahlai M, Nze C, Okwara N, Olds P, Paez R, Pardo M, Patel S, Petersen A, Phelan L, Pimenta E, Pipilas D, Plovanich M, Pong D, Powers BW, Rao A, Ramirez Batlle H, Ramsis M, Reichardt A, Reiger S, Rengarajan M, Rico S, Rome BN, Rosales R, Rotenstein L, Roy A, Royston S, Rozansky H, Rudder M, Ryan CE, Salgado S, Sanchez P, Schulte J, Sekar A, Semenkovich N, Shannon E, Shaw N, Shorten AB, Shrauner W, Sinnenberg L, Smithy JW, Snyder G, Sreekrishnan A, Stabenau H, Stavrou E,. Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center. Circ Heart Fail 12(11):e006214, 2019. e-Pub 2019. PMID: 31658831.
7. Green AR, Rosu C, Kenison T, Nze C. Assessing the hidden curriculum for the care of patients with limited english proficiency: An instrument development. Educ Health (Abingdon) 31(1):17-24, 2018. PMID: 30117468.
8. Green AR, Nze C. Language-Based Inequity in Health Care: Who Is the "Poor Historian"?. AMA J Ethics 19(3):263-271, 2017. e-Pub 2017. PMID: 28323607.

Editorials

1. Nze, C. and Nastoupil, L.J.. CAR T-cell Therapy: A Major Shift in the Treatment Landscape for Early-Relapse Aggressive B-Cell Lymphomas. The Hematologist 20(1), 2023.
2. Nze C. The Impact of Race on Mortality and Relapse in TTP. Practice update, 2022.
3. Nze C., Flowers CR. Analyzing Racial and Ethnic Disparities in Multiple Myeloma FDA Drug Approval Trials. Practice update, 2022.
4. Nze C.. Association of Race/Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Enrolled in VA and Medicare. Practice update, 2022.
5. Nze C., Flowers CR. Potential Impact of Nurse Navigation Program in Achieving Equitable Care and Outcomes in Patients With Aggressive Large B-Cell Lymphoma. ASCO Post, 2021.
6. Nze C. Socioeconomic Status and Suboptimal Iron Deficiency Screening in Pregnancy. Practice update, 2021.
7. Nze C. Eliminating Race-Based Reference Ranges in Hematology. Practice update, 2021.
8. Nze C., Avakame E., Ayankola J. Police brutality is our lane too, doctors say. STAT, 2020.

Abstracts

1. Chijioke Nze, Clark R Andersen, Amy Ayers, Jason Westin, Michael L. Wang, Swaminathan P. Iyer, Sairah Ahmed, Chelsea C. Pinnix, Francisco Vega, Lorna McNeil, Lynne Nguyen, Loretta J. Nastoupil, Christopher R. Flowers. Impact of Patient Demographics and Neighborhood Socioeconomic Variables on Clinical Trial Participation Patterns for Non-Hodgkin Lymphoma at a Major Academic Institution. Blood 140(1):7943–7945, 2022.
2. Chijioke Nze, MD, Brooke M Fortin, BA, BS, Revital Freedman, PhD, Maneka Puligandla, MS, Donna S Neuberg, ScD, Elyse Mandell, ANP, Maureen Achebe, MD MPH. Sudden Death in Sickle Cell Disease: An Assessment of Risk Factors. Blood, 2018.